Onconetix ( (ONCO) ) has released a notification of late filing.
Onconetix, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for the delay is the need for additional time to finalize financial statements, which could not be completed without unreasonable effort or expense. The company expects to file the report within the fifteen-day grace period allowed by the Securities Exchange Act. Significant changes in financial results are anticipated, including a substantial decrease in cash, accounts receivable, inventory, intangible assets, and goodwill, alongside changes in liabilities. These figures are still under review and may change upon final reporting. Onconetix is committed to ongoing compliance, with the notification signed by Karina Fedasz, the Interim Chief Financial Officer.
More about Onconetix
YTD Price Performance: -88.00%
Average Trading Volume: 7,450,285
Technical Sentiment Signal: Buy
Current Market Cap: $1.33M
For an in-depth examination of ONCO stock, go to TipRanks’ Stock Analysis page.